CAS RN 147536-97-8
Tocris Bioscience™ Bosentan
High affinity dual ETA and ETB receptor antagonist;orally bioavailable
Bosentan, TRC
CAS: 147536-97-8 Fórmula molecular: C27 H29 N5 O6 S Peso molecular (g/mol): 551.61 Sinónimo: Benzenesulfonamide, 4-(1,1-dimethylethyl)-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]-,4-(1,1-Dimethylethyl)-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]benzenesulfonamide,ACT 434964,Actelion,Bosentan,Ro 47-0203,Ro 47-0203/039,Tracleer,p-tert-Butyl-N-[6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]benzenesulfonamide Nombre IUPAC: 4-tert-butil-N-[6-(2-hidroxietoxi)-5-(2-metoxifenoxi)-2-pirimidina-2-ilpirimidina-4-il]benzenosulfonamida SMILES: COc1ccccc1Oc2c(NS(=O)(=O)c3ccc(cc3)C(C)(C)C)nc(nc2OCCO)c4ncccn4
Bosentan, MedChemExpress
MedChemExpress Bosentan is a competitive and dual antagonist of endothelin-1 (ET) for the ETA and ETB receptors with Ki of 4.7 nM and 95 nM in human SMC, respectively.